PREMIER BIOMEDICAL INC

Type: Company
Name: PREMIER BIOMEDICAL INC
First reported 7 hours ago - Updated 7 hours ago - 1 reports

Promising Medical Breakthroughs by Premier Biomedical, Inc.(BIEI)

(GLOBE NEWSWIRE) -- Uptick Newswire sat with President and CEO of Premier Biomedical Inc., Mr. William A. Hartman, to get the scoop on their medical miracles that are stretching scientific limits. Based in El Paso Texas., Premier Biomedical Inc. is working ... [Published Industrial Info Financials - 7 hours ago]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Premier Biomedical Retains Porter, LeVay and Rose as Investor Relations Council

Premier Biomedical, Inc ., a biopharmaceutical company focused on developing and commercializing innovative treatment therapies for cancer, traumatic brain injury, Alzheimer’s disease, and other afflictions announced today that it has retained the investor ... [Published Bulldog Reporter - Jul 24 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

PREMIER BIOMEDICAL : BIEI Announces Important Patent Award for a Potential Multi-Billion Dollar Drug for the Treatment of Fibromyalgia and...

Premier Biomedical, Inc. BIEI Announces Important Patent Award for a Potential Multi-Billion Dollar Drug for the Treatment of Fibromyalgia and NeuralgiaBy a News Reporter-Staff News Editor at Biotech Week -- Premier Biomedical, Inc. (OTCBB: "BIEI") a ... [Published 4 Traders - Jul 09 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Premier Biomedical wins patent

Premier Biomedical Inc., a biopharmaceutical company, announced that the U.S. Patent Office approved a patent on its proprietary medication Feldetrex, designed to relieve the symptoms of neuropathic pain and fibromyalgia. The William Beaumont Army Medical ... [Published El Paso Inc - Jul 08 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

El Paso's Premier Biomedical gets U.S. patent for pain medicine

REPORTER Vic KolenPremier Biomedical Inc., an El Paso start-up co-founded by an El Paso doctor, has received a U.S. patent on its recently developed medication, Feldetrex, which is designed to relieve symptoms of neuropathic pain and fibromyalgia, the ... [Published El Paso Times - Jul 03 2014]
First reported Jun 30 2014 - Updated Jun 30 2014 - 3 reports

Premier Biomedical, Inc. (BIEI) Announces Important Patent Award for a Potential Multi-Billion Dollar Drug for the Treatment of Fibromyalgia and Neuralgia

EL PASO, Texas--(EON: Enhanced Online News)--Premier Biomedical, Inc. (BIEI) Announces Important Patent Award for a Potential Multi-Billion Dollar Drug for the Treatment of Fibromyalgia and Neuralgia ... [Published EON Science - Jun 30 2014]
First reported Jun 17 2014 - Updated Jun 17 2014 - 3 reports

Premier Biomedical Releases Anti-CTLA4 Market Study

EL PASO, Texas--(EON: Enhanced Online News)--Premier Biomedical Releases Anti-CTLA4 Market Study. Premier Biomedical Inc. (OTCBB: BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune system manipulation. ... [Published EON Science - Jun 17 2014]
First reported May 08 2014 - Updated May 08 2014 - 5 reports

Premier Biomedical Enters Into Discussions with DOD to Initiate Staged Clinical Trials for Possible Head Trauma Cure

Premier Biomedical, Inc. (OTCBB: “BIEI”) a biopharmaceutical companyfocused on developing and commercializing innovative treatment therapiesfor cancer , traumatic brain injury, Alzheimer’s disease, and otherafflictions announced today that they have initiated ... [Published BioPortfolio - May 08 2014]
First reported Apr 24 2014 - Updated Apr 24 2014 - 4 reports

Premier Biomedical Receives Notice of Allowance on Broad Base Patent

Premier Biomedical, Inc. (OTCBB:BIEI) a biopharmaceutical companyfocused on developing and commercializing innovative immune-systemmanipulation therapies for breast cancer , as well as potential noveltherapies for Alzheimer ’s disease, multiple sclerosis ... [Published BioPortfolio - Apr 24 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 3 reports

Premier Biomedical’s CEO Invited to Speak at Brewer Sports Symposium V Featuring High-Level Executives and Industry Leaders Spanning Professional Sports

EL PASO, Texas--(EON: Enhanced Online News)--Premier Biomedical’s CEO Invited to Speak at Brewer Sports Symposium V Featuring High-Level Executives and Industry Leaders Spanning Professional Sports ... [Published EON Science - Apr 10 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 3 reports

Premier Biomedical Continues Progress on Anti-Cancer Treatment

EL PASO, Texas--(EON: Enhanced Online News)--Premier Biomedical Continues Progress on Anti-Cancer Treatment. ... [Published EON Science - Apr 02 2014]
First reported Mar 26 2014 - Updated Mar 27 2014 - 5 reports

Premier Biomedical Signs Agreement To Design Equipment For Clinical Trials

EL PASO, Texas--(EON: Enhanced Online News)--"BIEI" signs agreement on patent pending device for use with revolutionary technology for clinical trials. ... [Published EON Consumer - Mar 26 2014]

Quotes

President and CEO, William A Hartman , stated, "We are very excited that the United States Patent Office granted our request for a patent on Feldetrex ™. We are very confident in our ability to perform well in the upcoming double-blind clinical study because of the favorable responses we have received to datedate from the limited number of patients that have taken the medication thus far. We are applying for FDA approval immediately and are also confident that our application will be approved, since Feldetrex ™ consists only of a skillful and proprietary combination of FDA -approved ingredients. The market for such a medication worldwide runs into many billions of dollars. We believe that our medication will also fare very well versus competition due to its projected lack of serious side effects. The market should see results very quickly as the double-blind study is tentatively scheduled to be concluded later this calendar year." Safe Harbor Notice Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of...

More Content

All (34) | News (7) | Reports (0) | Blogs (27) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Promising Medical Breakthroughs by Premier Biom... [Published Industrial Info Financials - 7 hours ago]
Premier Biomedical Retains Porter, LeVay and Ro... [Published Bulldog Reporter - Jul 24 2014]
PREMIER BIOMEDICAL : BIEI Announces Important P... [Published 4 Traders - Jul 09 2014]
Premier Biomedical wins patent [Published El Paso Inc - Jul 08 2014]
El Paso's Premier Biomedical gets U.S. patent f... [Published El Paso Times - Jul 03 2014]
Premier Biomedical, Inc. (BIEI) Announces Impor... [Published EON Science - Jun 30 2014]
Premier Biomedical, Inc. (BIEI) Announces Impor... [Published Business Wire Science: Science News - Jun 30 2014]
Premier Biomedical, Inc. (BIEI) Announces Impor... [Published Business Wire Health News - Jun 30 2014]
Premier Biomedical Releases Anti-CTLA4 Market S... [Published EON Science - Jun 17 2014]
Premier Biomedical Releases Anti-CTLA4 Market S... [Published Business Wire Science: Science News - Jun 17 2014]
Premier Biomedical Releases Anti-CTLA4 Market S... [Published Business Wire Health News - Jun 17 2014]
Premier Biomedical Enters Into Discussions with... [Published BioPortfolio - May 08 2014]
Premier Biomedical Enters Into Discussions with... [Published EON Science - May 08 2014]
Premier Biomedical Enters Into Discussions with... [Published Business Wire Science: Science News - May 08 2014]
Premier Biomedical Enters Into Discussions with... [Published Business Wire Defense News - May 08 2014]
Premier Biomedical Enters Into Discussions with... [Published Business Wire Health News - May 08 2014]
Premier Biomedical Receives Notice of Allowance... [Published BioPortfolio - Apr 24 2014]
Premier Biomedical Receives Notice of Allowance... [Published EON Science - Apr 24 2014]
Premier Biomedical Receives Notice of Allowance... [Published Business Wire Science: Science News - Apr 24 2014]
Premier Biomedical Receives Notice of Allowance... [Published Business Wire Health News - Apr 24 2014]
Premier Biomedical’s CEO Invited to Speak at Br... [Published EON Science - Apr 10 2014]
Premier Biomedical’s CEO Invited to Speak at Br... [Published Business Wire Science: Science News - Apr 10 2014]
Premier Biomedical’s CEO Invited to Speak at Br... [Published Business Wire Health News - Apr 10 2014]
Premier Biomedical Continues Progress on Anti-C... [Published EON Science - Apr 02 2014]
Premier Biomedical Continues Progress on Anti-C... [Published Business Wire Science: Science News - Apr 02 2014]
Premier Biomedical Continues Progress on Anti-C... [Published Business Wire Health News - Apr 02 2014]
Premier Biomedical Signs Agreement To Design Eq... [Published EON Consumer - Mar 26 2014]
Premier Biomedical Signs Agreement To Design Eq... [Published EON Science - Mar 26 2014]
Premier Biomedical Signs Agreement To Design Eq... [Published Business Wire Science: Science News - Mar 26 2014]
Premier Biomedical Signs Agreement To Design Eq... [Published Business Wire Technology News - Mar 26 2014]
1 2
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Premier Biomedical, Inc. (BIEI) Announces Impor... [Published EON Science - Jun 30 2014]
EL PASO, Texas--(EON: Enhanced Online News)--Premier Biomedical, Inc. (BIEI) Announces Important Patent Award for a Potential Multi-Billion Dollar Drug for the Treatment of Fibromyalgia and Neuralgia ...
Premier Biomedical, Inc. (BIEI) Announces Impor... [Published Business Wire Science: Science News - Jun 30 2014]
EL PASO, Texas--(BUSINESS WIRE)--Premier Biomedical, Inc. (BIEI) Announces Important Patent Award for a Potential Multi-Billion Dollar Drug for the Treatment of Fibromyalgia and Neuralgia ...
Premier Biomedical, Inc. (BIEI) Announces Impor... [Published Business Wire Health News - Jun 30 2014]
EL PASO, Texas--(BUSINESS WIRE)--Premier Biomedical, Inc. (BIEI) Announces Important Patent Award for a Potential Multi-Billion Dollar Drug for the Treatment of Fibromyalgia and Neuralgia ...
Premier Biomedical Releases Anti-CTLA4 Market S... [Published EON Science - Jun 17 2014]
EL PASO, Texas--(EON: Enhanced Online News)--Premier Biomedical Releases Anti-CTLA4 Market Study. Premier Biomedical Inc. (OTCBB: BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune system manipulation. ...
Premier Biomedical Releases Anti-CTLA4 Market S... [Published Business Wire Science: Science News - Jun 17 2014]
EL PASO, Texas--(BUSINESS WIRE)--Premier Biomedical Releases Anti-CTLA4 Market Study. Premier Biomedical Inc. (OTCBB: BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune system manipulation. ...
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.